Skip to main content

Gout Therapeutics Market Size to hit US$ 9,815.6 million by 2026, with 15.2% CAGR from 2019 to 2026 | Market Study Report

Market Study Report LLC has a newly added "Global Gout Therapeutics Market Report" that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, and forecast in the coming years.

Delaware, Selbyville - August 8, 2019 /MarketersMedia/

The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1868592/?utm_source=marketersmedia-SP

The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report. Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.

As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share.

NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1868592/?utm_source=marketersmedia-SP

Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market.

The Report has segmented the global Gout Therapeutics Market on the basis of Drug Class, Disease Condition and region:
Gout Therapeutics by Drug Class Outlook (Revenue, USD Million, 2015 - 2026)
• Topical Hemostats
• Corticosteroids
• Nonsteroidal Anti-inflammatory Drugs [NSAIDs]
• Colchicine

Gout Therapeutics by Disease Condition Outlook (Revenue, USD Million, 2015 - 2026)
• Chronic Gout
• Acute Gout

Table of Content:

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Global Gout Therapeutics Testing Market Insights
3.1. Gout Therapeutics Market Industry snapshot
3.2. Gout Therapeutics Market Ecosystem analysis
3.3. Gout Therapeutics Market dynamics
3.3.1. Gout Therapeutics Market Forces
3.3.1.1. Gout Therapeutics Market - Market driver analysis
3.3.1.2. Gout Therapeutics Market - Market restraint/challenges analysis
3.3.1.3. Gout Therapeutics Market - Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Gout Therapeutics Market PEST analysis, 2017
3.6. Value Chain Analysis
3.7. Gout Therapeutics Market Industry trends
4. Gout Therapeutics Market Size and Forecast by Drug Class

5. Gout Therapeutics Market Size and Forecast by Disease Condition

6. Gout Therapeutics Market Size and Forecast by Regions

7. Gout Therapeutics Market Company Profiles

For more information on this report at: https://bit.ly/2yJVP3l

Related Report:

Global Gout Therapeutics Market Size, Status and Forecast 2019-2025

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction.

https://www.marketstudyreport.com/reports/global-gout-therapeutics-market-size-status-and-forecast-2019-2025?utm_source=RR-SP

Read more at: https://www.marketwatch.com/press-release/fruit-snacks-market-2019-industry-share-demand-global-trend-business-growth-top-key-players-update-and-forecast-to-2025-2019-08-02

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com

Source URL: https://marketersmedia.com/gout-therapeutics-market-size-to-hit-us-98156-million-by-2026-with-152-cagr-from-2019-to-2026-market-study-report/88905880

Source: MarketersMedia

Release ID: 88905880

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.